Leah Durant
Shoulder Injury Related to Vaccine Administration or SIRVA
HHS Terminates Effort to Limit VICP Coverage for SIRVA
Last year, the U.S. Department of Health and Human Services (HHS) began implementing measures that would have removed shoulder injuries related to vaccine administration (SIRVA) from the Vaccine Injury Table. The Vaccine Injury Table lists vaccine-related medical conditions that are eligible for compensation under the National Vaccine Compensation Program (VICP) without specific proof of causation. … Continue reading
Attorney Leah Durant Quoted in NBC Article Discussing SIRVA Compensation Claims
Our firm’s founder, vaccine attorney Leah V. Durant, was recently quoted in an NBC 4 Washington article discussing compensation claims for shoulder injuries related to vaccine administration (SIRVA). The article focused on the recent decision made by the U.S. Department of Health and Human Services (HHS) not to remove SIRVA from the National Vaccine Injury … Continue reading
How Long Do You Have to Seek Financial Compensation for SIRVA?
If you have been diagnosed with brachial neuritis, shoulder bursitis or any other type of shoulder injury related to vaccine administration (SIRVA), there is a lot you need to know. From dealing with unexpected medical bills to coping daily with chronic pain and physical limitations, a SIRVA diagnosis can impact nearly all aspects of your … Continue reading
CDC Offers New Resources to Help Health Care Providers with Vaccinations
For individuals who get vaccinated, one of the greatest risks is not the risk of an adverse reaction to the vaccine itself, but rather the risk of an injury resulting from an error during the vaccination process. Awareness of shoulder injuries related to vaccine administration (SIRVA) has grown significantly in recent years, and in 2018 … Continue reading
Reducing the Risk of SIRVA (and Its Long-Term Complications)
With a recent report concluding that vaccination errors account for more than half of all vaccine-related injuries, it is important for individuals who are getting vaccinated to be aware of the steps they (and their healthcare providers) can take to reduce the risk of shoulder injuries related to vaccine administration (SIRVA). Understanding Shoulder Injuries Related … Continue reading
Understanding the Long-Term Costs of SIRVA
For many people, shoulder pain following a vaccination is an early symptom of Shoulder Injury Related to Vaccine Administration, or “SIRVA.” Awareness of SIRVA has been growing in recent years; and, in 2017, the U.S. Health Resources and Services Administration (HRSA) added SIRVA to the Vaccine Injury Table under the National Vaccine Injury Compensation Program … Continue reading
Total VICP Payments Surpassed $4 Billion in Early 2019
The National Vaccine Injury Compensation Program (VICP) is a federal government program that provides a source of financial recovery for individuals who have been diagnosed with vaccine-related injuries and illnesses. While all vaccine-related injuries and illnesses are eligible for compensation under the VICP, most cases involve what are known as “on-table” injuries – medical conditions … Continue reading
The Reveal: News Investigation Reveals Alarming Facts about SIRVA
“Shoulder injuries related to vaccine administration,” or “SIRVA,” are potentially-serious injuries that result from errors during immunizations. While vaccines themselves can be harmful in some circumstances (i.e. when administered to someone who is allergic to a vaccine ingredient), an examination of recent claims filed under the National Vaccine Injury Compensation Program (VICP) revealed that about … Continue reading
FDA Approves Expanded Use of Afluria and Afluria Quadrivalent Flu Vaccines
In late 2018, the U.S. Food and Drug Administration (FDA) announced expanded approval of the Afluria and Afluria Quadrivalent flu vaccines. Previously approved for adults and children five years of age and older, the FDA’s expanded approval for Afluria and Afluria Quadrivalent now makes these vaccines available to children beginning at six months of age. … Continue reading
$135,000 Awarded to Prevnar Recipient Diagnosed with SIRVA
Prevnar is the name-brand pneumococcal conjugate vaccine. The Centers for Disease Control and Prevention (CDC) recommend that all children under the age of two and all adults age 65 and older receive a Prevnar immunization. Vaccination against pneumococcal disease with Prevnar is also recommended for individuals between the ages of two and 65 who have … Continue reading
Find Out More On Social Media
